The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Hindman Andrew A. since year 2005.
The trader's CIK number is 1607965.
At the time of this reporting, Hindman Andrew A. is the Chief Business Dev. Officer of Acorda Therapeutics Inc .
(stock ticker symbol ACOR).
See this page for all insider trading activities at Acorda Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-01||ACOR||Acorda Therapeutics Inc||Sale||817||20.54||16,784|
|2017-05-15||ACOR||Acorda Therapeutics Inc||Sale||7,704||15.75||121,322|
|2016-05-13||ACOR||Acorda Therapeutics Inc||Sale||4,860||26.11||126,884|
|2015-12-01||ACOR||Acorda Therapeutics Inc||Sale||442||38.26||16,910|
|2015-05-15||ACOR||Acorda Therapeutics Inc||Sale||475||30.16||14,326|
|2015-05-13||ACOR||Acorda Therapeutics Inc||Sale||4,304||29.78||128,168|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hindman Andrew A. (Chief Business Dev. Officer of Acorda Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.